{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T04:16:42Z","timestamp":1770437802755,"version":"3.49.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T00:00:00Z","timestamp":1436054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00403-015-1577-8","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T06:43:24Z","timestamp":1435992204000},"page":"645-657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["In silico database screening of potential targets and pathways of compounds contained in plants used for psoriasis vulgaris"],"prefix":"10.1007","volume":"307","author":[{"given":"Brian H.","family":"May","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony L.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanjian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlie C. L.","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,5]]},"reference":[{"key":"1577_CR1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood-2011-04-325225","volume":"119","author":"BB Aggarwal","year":"2012","unstructured":"Aggarwal BB, Gupta SC, Kim JH (2012) Historical perspectives on tumor necrosis factor and its superfamily: 25\u00a0years later, a golden journey. Blood 119:651\u2013665","journal-title":"Blood"},{"key":"1577_CR2","first-page":"3317","volume":"23","author":"D Andersson","year":"2003","unstructured":"Andersson D, Liu JJ, Nilsson A, Duan RD (2003) Ursolic acid inhibits proliferation and stimulates apoptosis in HT29 cells following activation of alkaline sphingomyelinase. Anticancer Res 23:3317\u20133322","journal-title":"Anticancer Res"},{"key":"1577_CR3","doi-asserted-by":"crossref","first-page":"D191","DOI":"10.1093\/nar\/gkt1140","volume":"42","author":"R Apweiler","year":"2014","unstructured":"Apweiler R, Bateman A, Martin MJ, O\u2019Donovan C, Magrane M, Alam-Faruque Y et al (2014) Activities at the universal protein resource (UniProt). Nucleic Acids Res 42:D191\u2013D198","journal-title":"Nucleic Acids Res"},{"key":"1577_CR4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1365-2133.2010.09935.x","volume":"163","author":"G Avramidis","year":"2010","unstructured":"Avramidis G, Kruger-Krasagakis S, Krasagakis K, Fragiadaki I, Kokolakis G, Tosca A (2010) The role of endothelial cell apoptosis in the effect of etanercept in psoriasis. Brit J Dermatol 163:928\u2013934","journal-title":"Brit J Dermatol"},{"key":"1577_CR5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-065X.2012.01095.x","volume":"246","author":"AS Baldwin","year":"2012","unstructured":"Baldwin AS (2012) Regulation of cell death and autophagy by IKK and NF-kappaB: critical mechanisms in immune function and cancer. Immunol Rev 246:327\u2013345","journal-title":"Immunol Rev"},{"key":"1577_CR6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jep.2012.01.041","volume":"140","author":"DJ Barlow","year":"2012","unstructured":"Barlow DJ, Buriani A, Ehrman T, Bosisio E, Eberini I, Hylands PJ (2012) In-silico studies in Chinese herbal medicines\u2019 research: evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date. J Ethnopharmacol 140:526\u2013534","journal-title":"J Ethnopharmacol"},{"key":"1577_CR7","first-page":"319","volume":"48","author":"T Batinac","year":"2007","unstructured":"Batinac T, Zamolo G, Hadzisejdic I, Zauhar G, Brumini G, Ruzic A et al (2007) Expression of Bcl-2 family proteins in psoriasis. Croat Med J 48:319\u2013326","journal-title":"Croat Med J"},{"key":"1577_CR8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.regpep.2007.09.004","volume":"146","author":"MT Bawolak","year":"2008","unstructured":"Bawolak MT, Touzin K, Moreau ME, Desormeaux A, Adam A, Marceau F (2008) Cardiovascular expression of inflammatory signaling molecules, the kinin B-1 receptor and COX2, in the rabbit: effects of LPS, anti-inflammatory and anti-hypertensive drugs. Regul Peptides 146:157\u2013168","journal-title":"Regul Peptides"},{"key":"1577_CR9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.nut.2008.03.023","volume":"24","author":"AW Boots","year":"2008","unstructured":"Boots AW, Wilms LC, Swennen ELR, Kleinjans JCS, Bast A, Haenen GRMM (2008) In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutrition 24:703\u2013710","journal-title":"Nutrition"},{"key":"1577_CR10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.mehy.2008.06.049","volume":"72","author":"L Cabrijan","year":"2009","unstructured":"Cabrijan L, Batinac T, Lenkovic M, Gruber F (2009) The distinction between lesional and non-lesional skin in psoriasis vulgaris through expression of adhesion molecules ICAM-1 and VCAM-1. Med Hypotheses 72:327\u2013329","journal-title":"Med Hypotheses"},{"key":"1577_CR11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jdermsci.2010.03.023","volume":"58","author":"M Canavese","year":"2010","unstructured":"Canavese M, Altruda F, Ruzicka T, Schauber J (2010) Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis\u2014a possible target for novel therapies? J Dermatol Sci 58:171\u2013176","journal-title":"J Dermatol Sci"},{"key":"1577_CR12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bcp.2013.11.008","volume":"87","author":"HH Cao","year":"2014","unstructured":"Cao HH, Tse AK, Kwan HY, Yu H, Cheng CY, Su T et al (2014) Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling. Biochem Pharmacol 87:424\u2013434","journal-title":"Biochem Pharmacol"},{"key":"1577_CR13","author":"XW Chen","year":"2012","unstructured":"Chen XW, Di YM, Zhang J, Zhou ZW, Li CG, Zhou SF (2012) Interaction of herbal compounds with biological targets: a case study with berberine. ScientificWorldJournal. doi: 10.1100\/2012\/708292","journal-title":"ScientificWorldJournal"},{"key":"1577_CR14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/jcb.20793","volume":"98","author":"YL Chen","year":"2006","unstructured":"Chen YL, Hu CS, Lin FY, Chen YH, Sheu LM, Ku HH et al (2006) Salvianolic acid B attenuates cyclooxygenase-2 expression in vitro in LPS-treated human aortic smooth muscle cells and in vivo in the apolipoprotein-E-deficient mouse aorta. J Cell Biochem 98:618\u2013631","journal-title":"J Cell Biochem"},{"key":"1577_CR15","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.jnutbio.2011.08.007","volume":"23","author":"JM Cho","year":"2012","unstructured":"Cho JM, Chang SY, Kim DB, Needs PW, Jo YH, Kim MJ (2012) Effects of physiological quercetin metabolites on interleukin-1beta-induced inducible NOS expression. J Nutr Biochem 23:1394\u20131402","journal-title":"J Nutr Biochem"},{"key":"1577_CR16","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s12272-001-2107-0","volume":"31","author":"EJ Choi","year":"2008","unstructured":"Choi EJ, Bae SM, Ahn WS (2008) Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells. Arch Pharm Res 31:1281\u20131285","journal-title":"Arch Pharm Res"},{"key":"1577_CR17","first-page":"565","volume":"17","author":"YH Choi","year":"2000","unstructured":"Choi YH, Baek JH, Yoo MA, Chung HY, Kim ND, Kim KW (2000) Induction of apoptosis by ursolic acid through activation of caspases and down-regulation of c-IAPs in human prostate epithelial cells. Int J Oncol 17:565\u2013571","journal-title":"Int J Oncol"},{"key":"1577_CR18","author":"Cohen Barak","year":"2015","unstructured":"Barak Cohen, Kerner M, Rozenman D, Ziv M (2015) Combination therapy of cyclosporine and anti-tumor necrosis factor \u03b1 in\u00a0psoriasis: a case series of 10 patients. Dermatol Ther. doi: 10.1111\/dth.12196","journal-title":"Dermatol Ther"},{"key":"1577_CR19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/bph.12294","volume":"170","author":"A Cortes-Cabrera","year":"2013","unstructured":"Cortes-Cabrera A, Morris GM, Finn PW, Morreale A, Gago F (2013) Comparison of ultra-fast 2D and 3D ligand and target descriptors for side effect prediction and network analysis in polypharmacology. Br J Pharmacol 170:557\u2013567","journal-title":"Br J Pharmacol"},{"key":"1577_CR20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1517\/13543784.2012.636351","volume":"21","author":"AA Crawshaw","year":"2012","unstructured":"Crawshaw AA, Griffiths CE, Young HS (2012) Investigational VEGF antagonists for psoriasis. Expert Opin Investig Drugs 21:33\u201343","journal-title":"Expert Opin Investig Drugs"},{"key":"1577_CR21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00403-013-1316-y","volume":"305","author":"S Deng","year":"2013","unstructured":"Deng S, May BH, Zhang AL, Lu C, Xue CC (2013) Topical herbal medicine combined with pharmacotherapy for psoriasis: a systematic review and meta-analysis. Arch Dermatol Res 305:179\u2013189","journal-title":"Arch Dermatol Res"},{"key":"1577_CR22","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/bjd.12557","volume":"169","author":"S Deng","year":"2013","unstructured":"Deng S, May BH, Zhang AL, Lu C, Xue CC (2013) Plant extracts for the topical management of psoriasis: a systematic review and meta-analysis. Br J Dermatol 169:769\u2013782","journal-title":"Br J Dermatol"},{"issue":"4","key":"1577_CR23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ptr.5028","volume":"28","author":"SQ Deng","year":"2014","unstructured":"Deng SQ, May BH, Zhang AL, Lu CJ, Xue CC (2014) Topical herbal formulae in the management of psoriasis: systematic review with meta-analysis of clinical studies and investigation of the pharmacological actions of the main herbs. Phytother Res 28(4):480\u2013497","journal-title":"Phytother Res"},{"issue":"3","key":"1577_CR24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00403-013-1428-4","volume":"306","author":"SQ Deng","year":"2014","unstructured":"Deng SQ, May BH, Zhang AL, Lu CJ, Xue CCL (2014) Phytotherapy in the management of psoriasis: a review of the efficacy and safety of oral interventions and the pharmacological actions of the main plants. Arch Dermatol Res 306(3):211\u2013229","journal-title":"Arch Dermatol Res"},{"key":"1577_CR25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/138945011793591626","volume":"12","author":"T Efferth","year":"2011","unstructured":"Efferth T, Koch E (2011) Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr Drug Targets 12:122\u2013132","journal-title":"Curr Drug Targets"},{"key":"1577_CR26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.bjp.0707306","volume":"152","author":"S Ekins","year":"2007","unstructured":"Ekins S, Mestres J, Testa B (2007) In silico pharmacology for drug discovery: applications to targets and beyond. Br J Pharmacol 152:21\u201337","journal-title":"Br J Pharmacol"},{"key":"1577_CR27","first-page":"46","volume":"3","author":"M El-Domyati","year":"2006","unstructured":"El-Domyati M, Barakat M, Abdel-Razek R (2006) Expression of apoptosis regulating proteins, P53 and Bcl-2, in psoriasis. J Egypt Wom Dermatol Soc 3:46\u201351","journal-title":"J Egypt Wom Dermatol Soc"},{"key":"1577_CR28","first-page":"65","volume":"5","author":"H Hadidi El","year":"2008","unstructured":"El Hadidi H, Huntar N, Zuyed A, El Mahgoub D, Nagui N, El Eishie N et al (2008) The effect of PUVA phototherapy on Bcl-2 expression in psoriasis vulgaris. J Egypt Wom Dermatol Soc 5:65\u201369","journal-title":"J Egypt Wom Dermatol Soc"},{"key":"1577_CR29","volume-title":"Impact of methotrexate on oxidative stress and apoptosis markers in psoriatic patients","author":"T Elango","year":"2013","unstructured":"Elango T, Dayalan H, Gnanaraj P, Malligarjunan H, Subramanian S (2013) Impact of methotrexate on oxidative stress and apoptosis markers in psoriatic patients. DOI, Clin Exp Med. doi: 10.1007\/s10238-013-0252-7"},{"key":"1577_CR30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/187221312798889248","volume":"6","author":"ME Garcia-Perez","year":"2012","unstructured":"Garcia-Perez ME, Jean J, Pouliot R (2012) Antipsoriatic drug development: challenges and new emerging therapies. Recent Pat Inflamm Allergy Drug Discov 6:3\u201321","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"1577_CR31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/jphp.12019","volume":"65","author":"SE George","year":"2013","unstructured":"George SE, Anderson RJ, Haswell M, Groundwater PW (2013) An investigation of the effects of dithranol-induced apoptosis in a human keratinocyte cell line. J Pharm Pharmacol 65:552\u2013560","journal-title":"J Pharm Pharmacol"},{"key":"1577_CR32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","volume":"69","author":"AM Goldminz","year":"2013","unstructured":"Goldminz AM, Au SC, Kim N, Gottlieb AB, Lizzul PF (2013) NF-kappaB: an essential transcription factor in psoriasis. J Dermatol Sci 69:89\u201394","journal-title":"J Dermatol Sci"},{"key":"1577_CR33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.clindermatol.2013.11.001","volume":"32","author":"I Grozdev","year":"2014","unstructured":"Grozdev I, Korman N, Tsankov N (2014) Psoriasis as a systemic disease. Clin Dermatol 32:343\u2013350","journal-title":"Clin Dermatol"},{"key":"1577_CR34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.abb.2014.06.006","volume":"559C","author":"SC Gupta","year":"2014","unstructured":"Gupta SC, Tyagi AK, Deshmukh-Taskar P, Hinojosa M, Prasad S, Aggarwal BB (2014) Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols. Arch Biochem Biophys 559C:91\u201399","journal-title":"Arch Biochem Biophys"},{"key":"1577_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.20588","volume":"114","author":"PO Harmand","year":"2005","unstructured":"Harmand PO, Duval R, Delage C, Simon A (2005) Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells. Int J Cancer 114:1\u201311","journal-title":"Int J Cancer"},{"key":"1577_CR36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1423-0127-18-30","volume":"18","author":"JH Ho","year":"2011","unstructured":"Ho JH, Hong CY (2011) Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection. J Biomed Sci 18:30","journal-title":"J Biomed Sci"},{"key":"1577_CR37","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/092986706776055698","volume":"13","author":"SM Jachak","year":"2006","unstructured":"Jachak SM (2006) Cyclooxygenase inhibitory natural products: current status. Curr Med Chem 13:659\u2013678","journal-title":"Curr Med Chem"},{"key":"1577_CR38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0091270005283282","volume":"46","author":"A Joshi","year":"2006","unstructured":"Joshi A, Bauer R, Kuebler P, White M, Leddy C, Compton P et al (2006) An overview of the pharmacokinetics and pharmacodynamics of efalizumab: a monoclonal antibody approved for use in psoriasis. J Clin Pharmacol 46:10\u201320","journal-title":"J Clin Pharmacol"},{"key":"1577_CR39","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1007\/s11033-011-1037-2","volume":"39","author":"A Kahraman","year":"2012","unstructured":"Kahraman A, Cakar H, Koken T (2012) The protective effect of quercetin on long-term alcohol consumption-induced oxidative stress. Mol Biol Rep 39:2789\u20132794","journal-title":"Mol Biol Rep"},{"key":"1577_CR40","doi-asserted-by":"crossref","first-page":"D355","DOI":"10.1093\/nar\/gkp896","volume":"38","author":"M Kanehisa","year":"2010","unstructured":"Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38:D355\u2013D360","journal-title":"Nucleic Acids Res"},{"key":"1577_CR41","first-page":"182","volume":"17","author":"M Kastelan","year":"2009","unstructured":"Kastelan M, Prpic-Massari L, Brajac I (2009) Apoptosis in psoriasis. Acta Dermatovener Croat 17:182\u2013186","journal-title":"Acta Dermatovener Croat"},{"key":"1577_CR42","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s12272-011-0817-5","volume":"34","author":"KH Kim","year":"2011","unstructured":"Kim KH, Seo HS, Choi HS, Choi I, Shin YC, Ko SG (2011) Induction of apoptotic cell death by ursolic acid through mitochondrial death pathway and extrinsic death receptor pathway in MDA-MB-231 cells. Arch Pharm Res 34:1363\u20131372","journal-title":"Arch Pharm Res"},{"key":"1577_CR43","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jep.2012.10.055","volume":"145","author":"MH Kim","year":"2013","unstructured":"Kim MH, Choi YY, Yang G, Cho IH, Nam D, Yang WM (2013) Indirubin, a purple 3,2-bisindole, inhibited allergic contact dermatitis via regulating T helper (Th)-mediated immune system in DNCB-induced model. J Ethnopharmacol 145:214\u2013219","journal-title":"J Ethnopharmacol"},{"key":"1577_CR44","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1365-4362.2003.01821.x","volume":"42","author":"M Kocak","year":"2003","unstructured":"Kocak M, Bozdogan O, Erkek E, Atasoy P, Birol A (2003) Examination of Bcl-2, Bcl-X and bax protein expression in psoriasis. Int J Dermatol 42:789\u2013793","journal-title":"Int J Dermatol"},{"key":"1577_CR45","first-page":"251","volume":"15","author":"D Koczan","year":"2005","unstructured":"Koczan D, Guthke R, Thiesen HJ, Ibrahim SM, Kundt G, Krentz H et al (2005) Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. Eur J Dermatol 15:251\u2013257","journal-title":"Eur J Dermatol"},{"key":"1577_CR46","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2133.2011.10689.x","volume":"166","author":"G Kokolakis","year":"2012","unstructured":"Kokolakis G, Giannikaki E, Stathopoulos E, Avramidis G, Tosca AD, Kruger-Krasagakis S (2012) Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions. Brit J Dermatol 166:491\u2013497","journal-title":"Brit J Dermatol"},{"key":"1577_CR47","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3892\/ijo.2013.2005","volume":"43","author":"MC Kowalczyk","year":"2013","unstructured":"Kowalczyk MC, Junco JJ, Kowalczyk P, Tolstykh O, Hanausek M, Slaga TJ et al (2013) Effects of combined phytochemicals on skin tumorigenesis in SENCAR mice. Int J Oncol 43:911\u2013918","journal-title":"Int J Oncol"},{"key":"1577_CR48","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cyto.2012.12.027","volume":"61","author":"EA Kupetsky","year":"2013","unstructured":"Kupetsky EA, Mathers AR, Ferris LK (2013) Anti-cytokine therapy in the treatment of psoriasis. Cytokine 61:704\u2013712","journal-title":"Cytokine"},{"key":"1577_CR49","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.freeradbiomed.2006.12.010","volume":"42","author":"W Langston","year":"2007","unstructured":"Langston W, Chidlow JH Jr, Booth BA, Barlow SC, Lefer DJ, Patel RP et al (2007) Regulation of endothelial glutathione by ICAM-1 governs VEGF-A-mediated eNOS activity and angiogenesis. Free Radic Biol Med 42:720\u2013729","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"1577_CR50","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00403-014-1480-8","volume":"306","author":"MS Leo","year":"2014","unstructured":"Leo, Sivamani RK (2014) Phytochemical modulation of the Akt\/mTOR pathway and its potential use in cutaneous disease. Arch Dermatol Res 306(10):861\u2013871","journal-title":"Arch Dermatol Res"},{"key":"1577_CR51","author":"FL Li","year":"2012","unstructured":"Li FL, Xu R, Zeng QC, Li X, Chen J, Wang YF et al (2012) Tanshinone IIA inhibits growth of keratinocytes through cell cycle arrest and apoptosis: underlying treatment mechanism of psoriasis. Evid-Based Compl Alt. doi: 10.1155\/2012\/927658","journal-title":"Evid-Based Compl Alt"},{"key":"1577_CR52","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1172\/JCI26322","volume":"115","author":"JL Luo","year":"2005","unstructured":"Luo JL, Kamata H, Karin M (2005) IKK\/NF-kappaB signaling: balancing life and death\u2014a new approach to cancer therapy. J Clin Invest 115:2625\u20132632","journal-title":"J Clin Invest"},{"key":"1577_CR53","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ptr.3171","volume":"24","author":"S Luqman","year":"2010","unstructured":"Luqman S, Pezzuto JM (2010) NFkappaB: a promising target for natural products in cancer chemoprevention. Phytother Res 24:949\u2013963","journal-title":"Phytother Res"},{"key":"1577_CR54","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.intimp.2008.02.013","volume":"8","author":"KA Manu","year":"2008","unstructured":"Manu KA, Kuttan G (2008) Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NF-kappaB mediated activation of bcl-2 in B16F-10 melanoma cells. Int Immunopharmacol 8:974\u2013981","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"1577_CR55","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s11655-012-1008-z","volume":"18","author":"BH May","year":"2012","unstructured":"May BH, Zhang AL, Zhou WY, Lu CJ, Deng SQ, Xue CCL (2012) Oral herbal medicines for psoriasis: a review of clinical studies. Chin J Integr Med 18(3):172\u2013178","journal-title":"Chin J Integr Med"},{"key":"1577_CR56","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nprot.2013.092","volume":"8","author":"H Mi","year":"2013","unstructured":"Mi H, Muruganujan A, Casagrande JT, Thomas PD (2013) Large-scale gene function analysis with the PANTHER classification system. Nat Protoc 8:1551\u20131566","journal-title":"Nat Protoc"},{"key":"1577_CR57","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12016-012-8306-2","volume":"44","author":"A Mitra","year":"2013","unstructured":"Mitra A, Fallen RS, Lima HC (2013) Cytokine-Based Therapy in Psoriasis. Clin Rev Allerg Immu 44:173\u2013182","journal-title":"Clin Rev Allerg Immu"},{"issue":"Suppl 1","key":"1577_CR58","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/sj.bjp.0707515","volume":"153","author":"N Moitessier","year":"2008","unstructured":"Moitessier N, Englebienne P, Lee D, Lawandi J, Corbeil CR (2008) Towards the development of universal, fast and highly accurate docking\/scoring methods: a long way to go. Br J Pharmacol 153(Suppl 1):S7\u2013S26","journal-title":"Br J Pharmacol"},{"key":"1577_CR59","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.fct.2013.09.024","volume":"62","author":"H Nam","year":"2013","unstructured":"Nam H, Kim MM (2013) Ursolic acid induces apoptosis of SW480 cells via p53 activation. Food Chem Toxicol 62:579\u2013583","journal-title":"Food Chem Toxicol"},{"issue":"10","key":"1577_CR60","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00403-013-1372-3","volume":"305","author":"A Nast","year":"2013","unstructured":"Nast A, Mrowietz U, Kragballe K, de Jong EM, Puig L, Reich K, Warren RB et al (2013) Barriers to the prescription of systemic therapies for moderate-to-severe psoriasis\u2014a multinational cross-sectional study. Arch Dermatol Res 305(10):899\u2013907","journal-title":"Arch Dermatol Res"},{"key":"1577_CR61","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1093\/carcin\/bgn151","volume":"29","author":"IT Nizamutdinova","year":"2008","unstructured":"Nizamutdinova IT, Lee GW, Lee JS, Cho MK, Son KH, Jeon SJ et al (2008) Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules. Carcinogenesis 29:1885\u20131892","journal-title":"Carcinogenesis"},{"key":"1577_CR62","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.acthis.2006.09.002","volume":"108","author":"P Oztas","year":"2006","unstructured":"Oztas P, Lortlar N, Oztas MO, Omeroglu S, Gurer MA, Alli N (2006) Caspase 9 is decreased in psoriatic epidermis. Acta Histochem 108:497\u2013499","journal-title":"Acta Histochem"},{"key":"1577_CR63","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.vph.2006.01.005","volume":"44","author":"NM Pandya","year":"2006","unstructured":"Pandya NM, Dhalla NS, Santani DD (2006) Angiogenesis\u2014a new target for future therapy. Vascul Pharmacol 44:265\u2013274","journal-title":"Vascul Pharmacol"},{"key":"1577_CR64","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1158\/1541-7786.MCR-06-0348","volume":"5","author":"AK Pathak","year":"2007","unstructured":"Pathak AK, Bhutani M, Nair AS, Ahn KS, Chakraborty A, Kadara H et al (2007) Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells. Mol Cancer Res 5:943\u2013955","journal-title":"Mol Cancer Res"},{"key":"1577_CR65","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.taap.2011.06.007","volume":"255","author":"AI Potapovich","year":"2011","unstructured":"Potapovich AI, Lulli D, Fidanza P, Kostyuk VA, De Luca C, Pastore S et al (2011) Plant polyphenols differentially modulate inflammatory responses of human keratinocytes by interfering with activation of transcription factors NFkappaB and AhR and EGFR-ERK pathway. Toxicol Appl Pharmacol 255:138\u2013149","journal-title":"Toxicol Appl Pharmacol"},{"key":"1577_CR66","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00018-010-0285-y","volume":"67","author":"LA Pradelli","year":"2010","unstructured":"Pradelli LA, Beneteau M, Ricci JE (2010) Mitochondrial control of caspase-dependent and -independent cell death. Cell Mol Life Sci 67:1589\u20131597","journal-title":"Cell Mol Life Sci"},{"issue":"18","key":"1577_CR67","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1158\/1078-0432.CCR-11-2805","volume":"18","author":"S Prasad","year":"2012","unstructured":"Prasad S, Yadav VR, Sung B, Reuter S, Kannappan R, Deorukhkar A et al (2012) Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine. Clin Cancer Res 18(18):4942\u20134953","journal-title":"Clin Cancer Res"},{"key":"1577_CR68","doi-asserted-by":"crossref","first-page":"e47516","DOI":"10.1371\/journal.pone.0047516","volume":"7","author":"P Pratheeshkumar","year":"2012","unstructured":"Pratheeshkumar P, Budhraja A, Son YO, Wang X, Zhang Z, Ding S et al (2012) Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR-2 regulated AKT\/mTOR\/P70S6\u00a0K signaling pathways. PLoS ONE 7:e47516","journal-title":"PLoS ONE"},{"key":"1577_CR69","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/10715762.2011.637204","volume":"46","author":"RV Priyadarsini","year":"2012","unstructured":"Priyadarsini RV, Nagini S (2012) Quercetin suppresses cytochrome P450 mediated ROS generation and NFkappaB activation to inhibit the development of 7,12-dimethylbenz[a]anthracene (DMBA) induced hamster buccal pouch carcinomas. Free Radic Res 46:41\u201349","journal-title":"Free Radic Res"},{"key":"1577_CR70","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1017\/S146239940900129X","volume":"11","author":"E Racz","year":"2009","unstructured":"Racz E, Prens EP (2009) Molecular pathophysiology of psoriasis and molecular targets of antipsoriatic therapy. Expert Rev Mol Med 11:e38. doi: 10.1017\/S146239940900129X","journal-title":"Expert Rev Mol Med"},{"key":"1577_CR71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/08923973.2010.487068","volume":"33","author":"G Raho","year":"2011","unstructured":"Raho G, Vena GA, Bizzoca A, Cassano N, Garofalo E, Congedo M et al (2011) Influence of infliximab on keratinocyte apoptosis in psoriasis patients. Immunopharm Immunot 33:227\u2013231","journal-title":"Immunopharm Immunot"},{"key":"1577_CR72","author":"A Saggini","year":"2014","unstructured":"Saggini A, Chimenti S, Chiricozzi A (2014) Il-6 as a druggable target in psoriasis: focus on pustular variants. J Immunol Res. doi: 10.1155\/2014\/964069","journal-title":"J Immunol Res"},{"key":"1577_CR73","author":"L Senggunprai","year":"2013","unstructured":"Senggunprai L, Kukongviriyapan V, Prawan A, Kukongviriyapan U (2013) Quercetin and EGCG exhibit chemopreventive effects in cholangiocarcinoma cells via suppression of JAK\/STAT signaling pathway. Phytother Res. doi: 10.1002\/ptr.5061","journal-title":"Phytother Res"},{"key":"1577_CR74","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.gt.3302306","volume":"12","author":"W Song","year":"2005","unstructured":"Song W, Sun Q, Dong Z, Spencer DM, Nunez G, Nor JE (2005) Antiangiogenic gene therapy: disruption of neovascular networks mediated by inducible caspase-9 delivered with a transcriptionally targeted adenoviral vector. Gene Ther 12:320\u2013329","journal-title":"Gene Ther"},{"key":"1577_CR75","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/jid.2012.184","volume":"132","author":"M Suarez-Farinas","year":"2012","unstructured":"Suarez-Farinas M, Li K, Fuentes-Duculan J, Hayden K, Brodmerkel C, Krueger JG (2012) Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J Invest Dermatol 132:2552\u20132564","journal-title":"J Invest Dermatol"},{"key":"1577_CR76","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1468-3083.2006.01916.x","volume":"21","author":"B Torres-Alvarez","year":"2007","unstructured":"Torres-Alvarez B, Castanedo-Cazares JP, Fuentes-Ahumada C, Moncada B (2007) The effect of methotrexate on the expression of cell adhesion molecules and activation molecule CD69 in psoriasis. J Eur Acad Dermatol 21:334\u2013339","journal-title":"J Eur Acad Dermatol"},{"key":"1577_CR77","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1477-3163-5-10","volume":"5","author":"MR Vijayababu","year":"2006","unstructured":"Vijayababu MR, Arunkumar A, Kanagaraj P, Arunakaran J (2006) Effects of quercetin on insulin-like growth factors (IGFs) and their binding protein-3 (IGFBP-3) secretion and induction of apoptosis in human prostate cancer cells. J Carcinog 5:10. doi: 10.1186\/1477-3163-5-10","journal-title":"J Carcinog"},{"key":"1577_CR78","first-page":"1079","volume":"146","author":"T Wrone-Smith","year":"1995","unstructured":"Wrone-Smith T, Johnson T, Nelson B, Boise LH, Thompson CB, Nunez G et al (1995) discordant expression of Bcl-x and Bcl-2 by keratinocytes in-vitro and psoriatic keratinocytes in-vivo. Am J Pathol 146:1079\u20131088","journal-title":"Am J Pathol"},{"key":"1577_CR79","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000068289","volume":"16","author":"T Yamamoto","year":"2003","unstructured":"Yamamoto T, Nishioka K (2003) Alteration of the expression of Bcl-2, Bcl-x, bax, fas, and fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy. Skin Pharmacol Appl 16:50\u201358","journal-title":"Skin Pharmacol Appl"},{"key":"1577_CR80","first-page":"86","volume":"37","author":"PY Yang","year":"2002","unstructured":"Yang PY, Rui YC, Zhang L, Li TJ, Qiu Y, Wang JS et al (2002) Expression of vascular endothelial growth factor in U937 foam cells and the inhibitory effect of drugs. Acta Pharmaceutica Sinica 37:86\u201389","journal-title":"Acta Pharmaceutica Sinica"},{"key":"1577_CR81","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1346-8138.2007.00290.x","volume":"34","author":"AC Yazici","year":"2007","unstructured":"Yazici AC, Karabulut AA, Ozen O, Eksioglu M, Ustun H (2007) Expression of p53 in lesions and unaffected skin of patients with plaque-type and guttate psoriasis: a quantitative comparative study. J Dermatol 34:367\u2013374","journal-title":"J Dermatol"},{"key":"1577_CR82","doi-asserted-by":"crossref","first-page":"D1055","DOI":"10.1093\/nar\/gkq1165","volume":"39","author":"H Ye","year":"2011","unstructured":"Ye H, Ye L, Kang H, Zhang D, Tao L, Tang K et al (2011) HIT: linking herbal active ingredients to targets. Nucleic Acids Res 39:D1055\u2013D1059","journal-title":"Nucleic Acids Res"},{"key":"1577_CR83","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1468-3083.2003.00805.x","volume":"17","author":"L Yildiz","year":"2003","unstructured":"Yildiz L, Baris S, Senturk N, Kandemir B (2003) Overexpression of bcl-2 in lymphocytes of psoriatic skin. J Eur Acad Dermatol 17:538\u2013540","journal-title":"J Eur Acad Dermatol"},{"key":"1577_CR84","volume-title":"Encyclopedia of traditional Chinese medicines: molecular structures, pharmacological activities, natural sources and applications","year":"2011","unstructured":"Zhou J, Xie G, Yan X (eds) (2011) Encyclopedia of traditional Chinese medicines: molecular structures, pharmacological activities, natural sources and applications. Springer, Dordrecht"},{"key":"1577_CR85","first-page":"565","volume":"26","author":"Y Zhou","year":"2010","unstructured":"Zhou Y, Li JS, Zhang X, Wu YJ, Huang K, Zheng L (2010) Ursolic acid inhibits early lesions of diabetic nephropathy. Int J Mol Med 26:565\u2013570","journal-title":"Int J Mol Med"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-015-1577-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-015-1577-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-015-1577-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T15:07:49Z","timestamp":1652800069000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-015-1577-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,5]]},"references-count":85,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["1577"],"URL":"https:\/\/doi.org\/10.1007\/s00403-015-1577-8","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,5]]}}}